Munich - Delayed Quote EUR

Harvard Bioscience Inc (HBI.MU)

0.4380
-0.0020
(-0.45%)
At close: June 13 at 5:25:00 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
91,397
94,135
112,250
113,335
118,904
Cost of Revenue
39,219
39,369
46,179
52,516
51,252
Gross Profit
52,178
54,766
66,071
60,819
67,652
Operating Expense
58,529
60,977
64,177
67,985
65,586
Operating Income
-6,351
-6,211
1,894
-7,166
2,066
Net Non Operating Interest Income Expense
-3,260
-3,209
-3,591
-2,548
-1,540
Other Income Expense
-48,364
-2,245
-859
535
-666
Pretax Income
-57,975
-11,665
-2,556
-9,179
-140
Tax Provision
76
740
859
337
148
Net Income Common Stockholders
-58,051
-12,405
-3,415
-9,516
-288
Diluted NI Available to Com Stockholders
-58,051
-12,405
-3,415
-9,516
-288
Basic EPS
-1.31
-0.28
-0.08
-0.23
-0.01
Diluted EPS
-1.31
-0.28
-0.08
-0.23
-0.01
Basic Average Shares
43,711.5000
43,538
42,420
41,413
40,343
Diluted Average Shares
43,711.5000
43,538
42,420
41,413
40,343
Total Operating Income as Reported
-53,600
-6,211
1,894
-6,933
2,066
Total Expenses
97,748
100,346
110,356
120,501
116,838
Net Income from Continuing & Discontinued Operation
-58,051
-12,405
-3,415
-9,516
-288
Normalized Income
-20,502.3000
-11,146.5300
-2,915.7200
-9,700.0700
-288
Interest Expense
3,260
3,209
3,591
2,548
1,540
Net Interest Income
-3,260
-3,209
-3,591
-2,548
-1,540
EBIT
-54,715
-8,456
1,035
-6,631
1,400
EBITDA
-47,684
-1,299
8,033
944
9,021
Reconciled Cost of Revenue
37,270
37,467
44,706
51,063
49,471
Reconciled Depreciation
7,031
7,157
6,998
7,575
7,621
Net Income from Continuing Operation Net Minority Interest
-58,051
-12,405
-3,415
-9,516
-288
Total Unusual Items Excluding Goodwill
-47,530
-1,593
-632
233
0
Total Unusual Items
-47,530
-1,593
-632
233
0
Normalized EBITDA
-154
294
8,665
711
9,021
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-9,981.3000
-334.5300
-132.7200
48.9300
0
12/31/2021 - 12/11/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

S5U5.DU Safilo Group SpA
0.8180
-3.08%
 
GXI.BE Gerresheimer AG
47.06
-1.47%
 
SAFLF Safilo Group S.p.A.
0.7600
0.00%
 
CBSC Cardiac Biotech Solutions Inc.
0.0440
0.00%
 
1ISRG.MI Intuitive Surgical, Inc.
446.20
+0.07%
 
6699.HK Angelalign Technology Inc.
57.650
-1.71%
 
SYNSAM.ST Synsam AB (publ)
53.70
-0.74%
 
COLOBc.XC
 
TSTL.L Tristel plc
377.50
-0.66%
 
IUI1.F Intuitive Surgical, Inc.
442.15
+0.03%